SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (522)4/23/1999 12:18:00 AM
From: Mike McFarland  Read Replies (1) of 4474
 
I know I get a little repetitive, and this one is
a bit off topic, being a neuro article an all, but
what the heck--the paper is a very easy read for those
of us who are newbies to biotech, so I'll post it.

Possible role of NF-kB and p53 in the glutamate
-induced pro-apoptotic neuronal pathway
stockton-press.co.uk
that's the url to Adobe PDF, go here for the abstract
stockton-press.co.uk

I know there are a whole gaggle of transciption factors,
but this one seems to keep coming up here and there.

Oh, did I mention this;-)
ARIAD is pursuing a series of related patent applications
on NF-kB, to which it holds an exclusive license.

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News